View all data FOR FREE!
Create an account today, no credit card required.
| Issue Type | XXXX |
|---|---|
| Country | United States |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2028-08-15 |
| Par Value | 2000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 450.00 |
| Coupon | 3.875 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 450 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Emergent Biosolutions Inc corporate note has a 3.88% fixed rate coupon paid on a semi-annual basis. It was issued on August 07, 2020 with an issue size of 450.00 million USD and matures on August 15, 2028 with a last coupon date of February 15, 2028. |
Emergent Biosolutions Inc, founded in 1998 and headquartered in Gaithersburg, Maryland, is a biopharmaceutical company focused on developing and manufacturing medical countermeasures for public health threats. The company specializes in vaccines, therapeutics, and diagnostics aimed at combating infectious diseases and biosecurity risks.